NVIC Articles

side-panel

Disease-Vaccine-Landing-Page/side-panel

Latest articles

Browse Articles

Placeholder image
Page

On June 30, 2020, the U.S. Food and Drug Administration (FDA) announced that a COVID-19 vaccine would only receive approval if it were at least 50 percent more effective than...

Placeholder image
Page

By mid-March and early April 2020, the WHO, National Institutes of Health  universities,  and global pharmaceutical corporations  had announced development of more than 50 experimental COVID-19 vaccines.   Responding to the call by...

Placeholder image
Page

For the past two decades, coronavirus vaccine research has been hampered by one consistent vaccine adverse outcome in particular - paradoxical immune enhancement (antibody disease enhancement). This outcome has not...

Placeholder image
Page

In September 2023, the FDA issued an EUA for an updated Moderna COVID-19 mRNA vaccine for use in children aged 6 months through 11 years of age to target the...

Placeholder image
Page

In October 2023, the FDA issued an EUA to Novavax for its adjuvanted COVID-19 vaccine containing spike protein from the Omicron XBB.1.5 variant of SARS-CoV-2. The FDA initially issued an EUA...

Placeholder image
Page

On September 11, 2023, the FDA approved an updated mRNA COVID-19 vaccine developed and manufactured by Moderna for use in persons 12 years and older to target the Omicron variant...

Placeholder image
Page

In September 2023, the FDA granted an EUA for an updated Pfizer-BioNTech mRNA COVID-19 vaccine for use in children aged 6 months through 4 years of age to target the...

Placeholder image
Page

In September 2023, the FDA issued an EUA for an updated Pfizer-BioNTech COVID-19 mRNA vaccine for use in children aged five through 11 years of age to target the Omicron...

Placeholder image
Page

In September 2023, the FDA approved an updated mRNA COVID-19 vaccine developed and manufactured by Pfizer-BioNTech for use in persons 12 years and older to target the Omicron variant XBB.1.5. Comirnaty...

Placeholder image
Page

According to the FDA, vaccine makers may submit an application to have their products approved under an Emergency Use Authorization (EUA). Under EUA authority, the FDA Commissioner may permit “unapproved medical...

Topics
Select disease / vaccine